Bayesian estimation of Lassa virus epidemiological parameters: Implications for spillover prevention using wildlife vaccination
dc.contributor.author | Nuismer, SL | |
dc.contributor.author | Remien, CH | |
dc.contributor.author | Basinski, AJ | |
dc.contributor.author | Varrelman, T | |
dc.contributor.author | Layman, N | |
dc.contributor.author | Rosenke, K | |
dc.contributor.author | Bird, B | |
dc.contributor.author | Jarvis, Michael A | |
dc.contributor.author | Barry, P | |
dc.contributor.author | Hanley, PW | |
dc.contributor.author | Fichet-Calvet, E | |
dc.date.accessioned | 2020-11-17T21:34:50Z | |
dc.date.issued | 2020-09-21 | |
dc.identifier.issn | 1935-2727 | |
dc.identifier.issn | 1935-2735 | |
dc.identifier.uri | http://hdl.handle.net/10026.1/16660 | |
dc.description.abstract |
Lassa virus is a significant burden on human health throughout its endemic region in West Africa, with most human infections the result of spillover from the primary rodent reservoir of the virus, the natal multimammate mouse, M. natalensis. Here we develop a Bayesian methodology for estimating epidemiological parameters of Lassa virus within its rodent reservoir and for generating probabilistic predictions for the efficacy of rodent vaccination programs. Our approach uses Approximate Bayesian Computation (ABC) to integrate mechanistic mathematical models, remotely-sensed precipitation data, and Lassa virus surveillance data from rodent populations. Using simulated data, we show that our method accurately estimates key model parameters, even when surveillance data are available from only a relatively small number of points in space and time. Applying our method to previously published data from two villages in Guinea estimates the time-averaged R0 of Lassa virus to be 1.74 and 1.54 for rodent populations in the villages of Bantou and Tanganya, respectively. Using the posterior distribution for model parameters derived from these Guinean populations, we evaluate the likely efficacy of vaccination programs relying on distribution of vaccine-laced baits. Our results demonstrate that effective and durable reductions in the risk of Lassa virus spillover into the human population will require repeated distribution of large quantities of vaccine. | |
dc.format.extent | e0007920-e0007920 | |
dc.format.medium | Electronic-eCollection | |
dc.language | en | |
dc.language.iso | en | |
dc.publisher | Public Library of Science (PLoS) | |
dc.subject | Animals | |
dc.subject | Bayes Theorem | |
dc.subject | Computer Simulation | |
dc.subject | Disease Reservoirs | |
dc.subject | Guinea | |
dc.subject | Lassa Fever | |
dc.subject | Lassa virus | |
dc.subject | Models, Theoretical | |
dc.subject | Murinae | |
dc.subject | Rodent Diseases | |
dc.subject | Vaccination | |
dc.subject | Zoonoses | |
dc.title | Bayesian estimation of Lassa virus epidemiological parameters: Implications for spillover prevention using wildlife vaccination | |
dc.type | journal-article | |
dc.type | Journal Article | |
dc.type | Research Support, N.I.H., Extramural | |
dc.type | Research Support, N.I.H., Intramural | |
dc.type | Research Support, U.S. Gov't, Non-P.H.S. | |
plymouth.author-url | https://www.ncbi.nlm.nih.gov/pubmed/32956349 | |
plymouth.issue | 9 | |
plymouth.volume | 14 | |
plymouth.publication-status | Published online | |
plymouth.journal | PLOS Neglected Tropical Diseases | |
dc.identifier.doi | 10.1371/journal.pntd.0007920 | |
plymouth.organisational-group | /Plymouth | |
plymouth.organisational-group | /Plymouth/Faculty of Health | |
plymouth.organisational-group | /Plymouth/Faculty of Health/School of Biomedical Sciences | |
plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA | |
plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine | |
plymouth.organisational-group | /Plymouth/Research Groups | |
plymouth.organisational-group | /Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED) | |
plymouth.organisational-group | /Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)/CBR | |
plymouth.organisational-group | /Plymouth/Users by role | |
plymouth.organisational-group | /Plymouth/Users by role/Academics | |
dc.publisher.place | United States | |
dcterms.dateAccepted | 2020-07-20 | |
dc.rights.embargodate | 2020-11-19 | |
dc.identifier.eissn | 1935-2735 | |
dc.rights.embargoperiod | Not known | |
rioxxterms.versionofrecord | 10.1371/journal.pntd.0007920 | |
rioxxterms.licenseref.uri | http://www.rioxx.net/licenses/all-rights-reserved | |
rioxxterms.licenseref.startdate | 2020-09-21 | |
rioxxterms.type | Journal Article/Review |